Report

Global RNA-interference (RNAi) Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries

  • Publish Date: Jul,2022
  • Report ID: QI045
  • Page : 112
  • Report Type : PDF
Table of Content

1 RNA-interference (RNAi) Market Definition and Overview
1.1 Objectives of the Study
1.2 Overview of RNA-interference (RNAi)
1.3 RNA-interference (RNAi) Market Scope and Market Size Estimation
1.4 Market Segmentation
1.4.1 Types of RNA-interference (RNAi)
1.4.2 Applications of RNA-interference (RNAi)
1.5 Market Exchange Rate

2 Research Method and Logic
2.1 Methodology
2.2 Research Data Source

3 Market Competition Analysis
3.1 Qiagen NV Market Performance Analysis
3.1.1 Qiagen NV Basic Information
3.1.2 Product and Service Analysis
3.1.3 Strategies for Company to Deal with the Impact of COVID-19
3.1.4 Qiagen NV Sales, Value, Price, Gross Margin 2016-2021
3.2 Phio Pharmaceuticals Corp. Market Performance Analysis
3.2.1 Phio Pharmaceuticals Corp. Basic Information
3.2.2 Product and Service Analysis
3.2.3 Strategies for Company to Deal with the Impact of COVID-19
3.2.4 Phio Pharmaceuticals Corp. Sales, Value, Price, Gross Margin 2016-2021
3.3 Benitec Biopharma Ltd Market Performance Analysis
3.3.1 Benitec Biopharma Ltd Basic Information
3.3.2 Product and Service Analysis
3.3.3 Strategies for Company to Deal with the Impact of COVID-19
3.3.4 Benitec Biopharma Ltd Sales, Value, Price, Gross Margin 2016-2021
3.4 Tekmira Pharmaceuticals Corporation Market Performance Analysis
3.4.1 Tekmira Pharmaceuticals Corporation Basic Information
3.4.2 Product and Service Analysis
3.4.3 Strategies for Company to Deal with the Impact of COVID-19
3.4.4 Tekmira Pharmaceuticals Corporation Sales, Value, Price, Gross Margin 2016-2021
3.5 RXI Pharmaceuticals Market Performance Analysis
3.5.1 RXI Pharmaceuticals Basic Information
3.5.2 Product and Service Analysis
3.5.3 Strategies for Company to Deal with the Impact of COVID-19
3.5.4 RXI Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.6 Dicerna Pharmaceuticals Market Performance Analysis
3.6.1 Dicerna Pharmaceuticals Basic Information
3.6.2 Product and Service Analysis
3.6.3 Strategies for Company to Deal with the Impact of COVID-19
3.6.4 Dicerna Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.7 Arcturus Therapeutics Market Performance Analysis
3.7.1 Arcturus Therapeutics Basic Information
3.7.2 Product and Service Analysis
3.7.3 Strategies for Company to Deal with the Impact of COVID-19
3.7.4 Arcturus Therapeutics Sales, Value, Price, Gross Margin 2016-2021
3.8 Silence Therapeutics PLC Market Performance Analysis
3.8.1 Silence Therapeutics PLC Basic Information
3.8.2 Product and Service Analysis
3.8.3 Strategies for Company to Deal with the Impact of COVID-19
3.8.4 Silence Therapeutics PLC Sales, Value, Price, Gross Margin 2016-2021
3.9 Arrowhead Market Performance Analysis
3.9.1 Arrowhead Basic Information
3.9.2 Product and Service Analysis
3.9.3 Strategies for Company to Deal with the Impact of COVID-19
3.9.4 Arrowhead Sales, Value, Price, Gross Margin 2016-2021
3.10 Thermo Fisher Scientific Inc. Market Performance Analysis
3.10.1 Thermo Fisher Scientific Inc. Basic Information
3.10.2 Product and Service Analysis
3.10.3 Strategies for Company to Deal with the Impact of COVID-19
3.10.4 Thermo Fisher Scientific Inc. Sales, Value, Price, Gross Margin 2016-2021
3.11 Alnylam Pharmaceuticals Market Performance Analysis
3.11.1 Alnylam Pharmaceuticals Basic Information
3.11.2 Product and Service Analysis
3.11.3 Strategies for Company to Deal with the Impact of COVID-19
3.11.4 Alnylam Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.12 Ionis Pharmaceuticals Inc. Market Performance Analysis
3.12.1 Ionis Pharmaceuticals Inc. Basic Information
3.12.2 Product and Service Analysis
3.12.3 Strategies for Company to Deal with the Impact of COVID-19
3.12.4 Ionis Pharmaceuticals Inc. Sales, Value, Price, Gross Margin 2016-2021
3.13 Merck & Co. Inc. (Sigma Aldrich) Market Performance Analysis
3.13.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information
3.13.2 Product and Service Analysis
3.13.3 Strategies for Company to Deal with the Impact of COVID-19
3.13.4 Merck & Co. Inc. (Sigma Aldrich) Sales, Value, Price, Gross Margin 2016-2021
3.14 ISIS Pharmaceuticals Market Performance Analysis
3.14.1 ISIS Pharmaceuticals Basic Information
3.14.2 Product and Service Analysis
3.14.3 Strategies for Company to Deal with the Impact of COVID-19
3.14.4 ISIS Pharmaceuticals Sales, Value, Price, Gross Margin 2016-2021
3.15 Quark Pharmaceuticals Inc. Market Performance Analysis
3.15.1 Quark Pharmaceuticals Inc. Basic Information
3.15.2 Product and Service Analysis
3.15.3 Strategies for Company to Deal with the Impact of COVID-19
3.15.4 Quark Pharmaceuticals Inc. Sales, Value, Price, Gross Margin 2016-2021

4 Market Segment by Type, Historical Data and Market Forecasts
4.1 Global RNA-interference (RNAi) Production and Value by Type
4.1.1 Global RNA-interference (RNAi) Production by Type 2016-2021
4.1.2 Global RNA-interference (RNAi) Market Value by Type 2016-2021
4.2 Global RNA-interference (RNAi) Market Production, Value and Growth Rate by Type 2016-2021
4.2.1 Chemical synthesis Market Production, Value and Growth Rate
4.2.2 In vitro transcription Market Production, Value and Growth Rate
4.2.3 In vivo expression Market Production, Value and Growth Rate
4.3 Global RNA-interference (RNAi) Production and Value Forecast by Type
4.3.1 Global RNA-interference (RNAi) Production Forecast by Type 2021-2026
4.3.2 Global RNA-interference (RNAi) Market Value Forecast by Type 2021-2026
4.4 Global RNA-interference (RNAi) Market Production, Value and Growth Rate by Type Forecast 2021-2026
4.4.1 Chemical synthesis Market Production, Value and Growth Rate Forecast
4.4.2 In vitro transcription Market Production, Value and Growth Rate Forecast
4.4.3 In vivo expression Market Production, Value and Growth Rate Forecast

5 Market Segment by Application, Historical Data and Market Forecasts
5.1 Global RNA-interference (RNAi) Consumption and Value by Application
5.1.1 Global RNA-interference (RNAi) Consumption by Application 2016-2021
5.1.2 Global RNA-interference (RNAi) Market Value by Application 2016-2021
5.2 Global RNA-interference (RNAi) Market Consumption, Value and Growth Rate by Application 2016-2021
5.2.1 Drug Discovery and Development Market Consumption, Value and Growth Rate
5.2.2 Therapeutics Market Consumption, Value and Growth Rate
5.3 Global RNA-interference (RNAi) Consumption and Value Forecast by Application
5.3.1 Global RNA-interference (RNAi) Consumption Forecast by Application 2021-2026
5.3.2 Global RNA-interference (RNAi) Market Value Forecast by Application 2021-2026
5.4 Global RNA-interference (RNAi) Market Consumption, Value and Growth Rate by Application Forecast 2021-2026
5.4.1 Drug Discovery and Development Market Consumption, Value and Growth Rate Forecast
5.4.2 Therapeutics Market Consumption, Value and Growth Rate Forecast

6 Global RNA-interference (RNAi) by Region, Historical Data and Market Forecasts
6.1 Global RNA-interference (RNAi) Sales by Region 2016-2021
6.2 Global RNA-interference (RNAi) Market Value by Region 2016-2021
6.3 Global RNA-interference (RNAi) Market Sales, Value and Growth Rate by Region 2016-2021
6.3.1 North America
6.3.2 Europe
6.3.3 Asia Pacific
6.3.4 South America
6.3.5 Middle East and Africa
6.4 Global RNA-interference (RNAi) Sales Forecast by Region 2021-2026
6.5 Global RNA-interference (RNAi) Market Value Forecast by Region 2021-2026
6.6 Global RNA-interference (RNAi) Market Sales, Value and Growth Rate Forecast by Region 2021-2026
6.6.1 North America
6.6.2 Europe
6.6.3 Asia Pacific
6.6.4 South America
6.6.5 Middle East and Africa

7 United State Market Size Analysis 2016-2026
7.1 United State RNA-interference (RNAi) Value and Market Growth 2016-2021
7.2 United State RNA-interference (RNAi) Sales and Market Growth 2016-2021
7.3 United State RNA-interference (RNAi) Market Value Forecast 2021-2026

8 Canada Market Size Analysis 2016-2026
8.1 Canada RNA-interference (RNAi) Value and Market Growth 2016-2021
8.2 Canada RNA-interference (RNAi) Sales and Market Growth 2016-2021
8.3 Canada RNA-interference (RNAi) Market Value Forecast 2021-2026

9 Germany Market Size Analysis 2016-2026
9.1 Germany RNA-interference (RNAi) Value and Market Growth 2016-2021
9.2 Germany RNA-interference (RNAi) Sales and Market Growth 2016-2021
9.3 Germany RNA-interference (RNAi) Market Value Forecast 2021-2026

10 UK Market Size Analysis 2016-2026
10.1 UK RNA-interference (RNAi) Value and Market Growth 2016-2021
10.2 UK RNA-interference (RNAi) Sales and Market Growth 2016-2021
10.3 UK RNA-interference (RNAi) Market Value Forecast 2021-2026

11 France Market Size Analysis 2016-2026
11.1 France RNA-interference (RNAi) Value and Market Growth 2016-2021
11.2 France RNA-interference (RNAi) Sales and Market Growth 2016-2021
11.3 France RNA-interference (RNAi) Market Value Forecast 2021-2026

12 Italy Market Size Analysis 2016-2026
12.1 Italy RNA-interference (RNAi) Value and Market Growth 2016-2021
12.2 Italy RNA-interference (RNAi) Sales and Market Growth 2016-2021
12.3 Italy RNA-interference (RNAi) Market Value Forecast 2021-2026

13 Spain Market Size Analysis 2016-2026
13.1 Spain RNA-interference (RNAi) Value and Market Growth 2016-2021
13.2 Spain RNA-interference (RNAi) Sales and Market Growth 2016-2021
13.3 Spain RNA-interference (RNAi) Market Value Forecast 2021-2026

14 Russia Market Size Analysis 2016-2026
14.1 Russia RNA-interference (RNAi) Value and Market Growth 2016-2021
14.2 Russia RNA-interference (RNAi) Sales and Market Growth 2016-2021
14.3 Russia RNA-interference (RNAi) Market Value Forecast 2021-2026

15 China Market Size Analysis 2016-2026
15.1 China RNA-interference (RNAi) Value and Market Growth 2016-2021
15.2 China RNA-interference (RNAi) Sales and Market Growth 2016-2021
15.3 China RNA-interference (RNAi) Market Value Forecast 2021-2026

16 Japan Market Size Analysis 2016-2026
16.1 Japan RNA-interference (RNAi) Value and Market Growth 2016-2021
16.2 Japan RNA-interference (RNAi) Sales and Market Growth 2016-2021
16.3 Japan RNA-interference (RNAi) Market Value Forecast 2021-2026

17 South Korea Market Size Analysis 2016-2026
17.1 South Korea RNA-interference (RNAi) Value and Market Growth 2016-2021
17.2 South Korea RNA-interference (RNAi) Sales and Market Growth 2016-2021
17.3 South Korea RNA-interference (RNAi) Market Value Forecast 2021-2026

18 Australia Market Size Analysis 2016-2026
18.1 Australia RNA-interference (RNAi) Value and Market Growth 2016-2021
18.2 Australia RNA-interference (RNAi) Sales and Market Growth 2016-2021
18.3 Australia RNA-interference (RNAi) Market Value Forecast 2021-2026

19 Thailand Market Size Analysis 2016-2026
19.1 Thailand RNA-interference (RNAi) Value and Market Growth 2016-2021
19.2 Thailand RNA-interference (RNAi) Sales and Market Growth 2016-2021
19.3 Thailand RNA-interference (RNAi) Market Value Forecast 2021-2026

20 Brazil Market Size Analysis 2016-2026
20.1 Brazil RNA-interference (RNAi) Value and Market Growth 2016-2021
20.2 Brazil RNA-interference (RNAi) Sales and Market Growth 2016-2021
20.3 Brazil RNA-interference (RNAi) Market Value Forecast 2021-2026

21 Argentina Market Size Analysis 2016-2026
21.1 Argentina RNA-interference (RNAi) Value and Market Growth 2016-2021
21.2 Argentina RNA-interference (RNAi) Sales and Market Growth 2016-2021
21.3 Argentina RNA-interference (RNAi) Market Value Forecast 2021-2026

22 Chile Market Size Analysis 2016-2026
22.1 Chile RNA-interference (RNAi) Value and Market Growth 2016-2021
22.2 Chile RNA-interference (RNAi) Sales and Market Growth 2016-2021
22.3 Chile RNA-interference (RNAi) Market Value Forecast 2021-2026

23 South Africa Market Size Analysis 2016-2026
23.1 South Africa RNA-interference (RNAi) Value and Market Growth 2016-2021
23.2 South Africa RNA-interference (RNAi) Sales and Market Growth 2016-2021
23.3 South Africa RNA-interference (RNAi) Market Value Forecast 2021-2026

24 Egypt Market Size Analysis 2016-2026
24.1 Egypt RNA-interference (RNAi) Value and Market Growth 2016-2021
24.2 Egypt RNA-interference (RNAi) Sales and Market Growth 2016-2021
24.3 Egypt RNA-interference (RNAi) Market Value Forecast 2021-2026

25 UAE Market Size Analysis 2016-2026
25.1 UAE RNA-interference (RNAi) Value and Market Growth 2016-2021
25.2 UAE RNA-interference (RNAi) Sales and Market Growth 2016-2021
25.3 UAE RNA-interference (RNAi) Market Value Forecast 2021-2026

26 Saudi Arabia Market Size Analysis 2016-2026
26.1 Saudi Arabia RNA-interference (RNAi) Value and Market Growth 2016-2021
26.2 Saudi Arabia RNA-interference (RNAi) Sales and Market Growth 2016-2021
26.3 Saudi Arabia RNA-interference (RNAi) Market Value Forecast 2021-2026

27 Market Dynamic Analysis and Development Suggestions
27.1 Market Drivers
27.2 Market Development Constraints
27.3 PEST Analysis
27.3.1 Political Factors
27.3.2 Economic Factors
27.3.3 Social Factors
27.3.4 Technological Factors
27.4 Industry Trends Under COVID-19
27.4.1 Risk Assessment on COVID-19
27.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
27.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
27.5 Market Entry Strategy Analysis
27.5.1 Market Definition
27.5.2 Client
27.5.3 Distribution Model
27.5.4 Product Messaging and Positioning
27.5.5 Price
27.6 Advice on Entering the Market